Plain-English translation of NCT06335693 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing hypofractionated radiotherapy — a type of radiation treatment delivered in fewer, more concentrated doses — for men who have had their prostate surgically removed and have signs that their cancer may return. Instead of the traditional longer course of radiation, this study gives the treatment in 15 sessions, aiming to be equally effective while potentially causing fewer side effects.
After prostate removal surgery, some men have cancer features that put them at higher risk of the disease coming back. Adding radiation therapy can help prevent recurrence, but doctors want to find ways to deliver this treatment more efficiently and with fewer side effects on the bladder and bowel.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive radiation therapy in 15 treatment sessions, typically delivered over 3 weeks. You will attend appointments at the hospital for your radiation treatments and have follow-up visits where doctors will monitor you for any side effects and check your PSA levels and imaging scans to see how well the treatment is working. The study will also ask you to complete questionnaires about your quality of life and any urinary or bowel symptoms you experience.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
China